Gabapentin Tablet, Film Coated
Product Images NDC 76282-405

This is a description of a medication called "Gabapentin Tablets, USP" with a dosage of 600mg. There is a message to the pharmacist to dispense a medication guide separately to each patient. The medication is to be stored between 20°C to 25°C (68°F to 77°F). The dosage and use information is provided in the package insert. The medication should be dispensed in a tight container with a child-resistant closure. The medication is manufactured for Belan Pharmaceuticals located in Boca Raton, FL 33432.*

Gabapentin is a drug available in tablet form, with each tablet containing 600 mg of the active ingredient, USP. It is manufactured by Invaen Pharmaceuticals, a subsidiary of Cipl Ltd, and is intended for distribution by Belan Pharmaceuticals. The medication guide is to be provided to patients separately, and prescribing information can be found in the package insert. The tablets should be stored in a tight container at a controlled room temperature between 20° and 25°C (68°- 77°F) and dispensed with a child-resistant closure.*

Gabapentin Tablets, USP 800 mg is a medication used for the treatment of neuropathic pain and seizures. It comes in a bottle that contains 90 tablets, and each tablet contains 800mg of gabapentin. The medication should be stored between 20°-25°C (68°-77°F) as controlled by USP. It is to be dispensed in a tightly sealed container with a child-resistant closure. The full prescribing information can be found inside the package of the medication. The medication guide should be given to each patient. The manufacturer of this medication is Ascent Pharmaceuticals, Inc., located in Central Islip, NY, and manufactured for Exelan Pharmaceuticals, Inc, located in Boca Raton, FL.*

This is a medication information for Gaba Pentin - tablets, USP with 800mg of Gabapentin per tablets in a child-resistant container. It is manufactured by Ivagen Pharmaceuticals and distributed by Exelan Pharmaceuticals. A medication guide is provided separately to each patient. This is prescription medication (Rx only) and comes in a pack of 90 tablets.*

The text describes a chart or graph with the mean pain score over the course of a 4-week dose titration period and 4-week fixed dose period. The chart includes data for a placebo and gabapentin at a dosage of 3600 mg/day. The chart also includes baseline and 8 weeks measurement.*

This text provides a chart (Figure 3) that shows the proportion of responders in controlled PHN studies. The chart presents data for two studies (Study 1 and Study 2) and indicates that in Study 2, 34% of patients showed a reduction in pain score greater than 50%. The text also shows the statistical significance of this result (p<0.001). Additionally, the text mentions some medication dosages: GEP 3600, GBP 1800, and GBP 2400, although it is unclear in what context they are referred to.*

This appears to be a formula used for estimating creatinine clearance (CLCr) in patients based on their age, weight, and serum creatinine levels. However, without additional information on the context and applicability of this formula, it cannot be fully understood or utilized.*